Emergency transapical mitral valve-in-valve implantation for bioprosthesis failure: transapical implantation of an Edwards Sapien-XT in a dysfunctional mitral bioprosthesis in a critical patient

BACKGROUND: Valve-in-Valve (VIV) Transcatheter Aortic Valve Replacement (TAVR) is now the treatment of choice in high-surgical-risk patients with failing aortic bioprosthesis. Although less performed, VIV-Transcatheter Mitral Valve Replacement (TMVR) is a valid treatment option for selected high-ris...

Descripción completa

Detalles Bibliográficos
Autores principales: Zanobini, Marco, Manganiello, Sabrina, Bonalumi, Giorgia, Biondi, Raoul, Russo, Marco, Mapelli, Massimo, Alamanni, Francesco, Saccocci, Matteo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729393/
https://www.ncbi.nlm.nih.gov/pubmed/29237501
http://dx.doi.org/10.1186/s13019-017-0680-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729393/
https://www.ncbi.nlm.nih.gov/pubmed/29237501
http://dx.doi.org/10.1186/s13019-017-0680-7

Ejemplares similares